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The bi-directional nature of the interaction between 
conventional sexually transmitted infections (STIs) and HIV 
has been documented in many studies.1,2 It has come to be 
recognised that the presence of STIs can increase the risk of 
acquisition of HIV infection and also promote its transmission, 
while HIV infection and associated immunodeficiency can 
alter the natural history and influence the diagnosis and 
management of conventional STIs.3-5 The magnitude of the 
impact of this interaction is more evident in developing 
countries where the twin epidemics of HIV infection and 
conventional STIs coexist and produce a vicious cycle that is 
less evident in more developed societies. During the 1990s, 
several studies indicated that the incidence of HIV among 
patients with STIs was significantly higher than those without. 
This association was more pronounced among those patients 
presenting with genital ulcer disease (GUD).6-9
As a cause of GUD, syphilis is associated with an increased 
risk of both acquisition and transmission of HIV. Establishment 
of a definitive diagnosis in cases of primary syphilis is 
important in order to provide appropriate therapy as soon 
as possible to prevent spread of both syphilis and HIV (in 
the co-infected) and reduce the risk of acquisition of HIV (in 
those not already infected). Unfortunately, techniques to detect 
Treponema pallidum in primary lesions (either by darkfield 
microscopy, direct immunofluorescence or amplified molecular 
technologies) are usually not available in most settings in 
developing countries, and clinicians usually have to rely on 
serological tests to establish a diagnosis.
Several studies have suggested that concomitant HIV 
infection may change the performance characteristics of 
serological tests for syphilis.10-14 In these studies, we have 
investigated the utility of both a non-treponemal (RPR) test 
and a treponemal (FTA-ABS) test for the diagnosis of primary 
syphilis during the emergence of the HIV epidemic in southern 
Africa.
Patients and methods
Patients
Eight hundred and sixty-eight patients with genital ulcerations 
were enrolled in five aetiological studies conducted in Maseru 
(Lesotho), Johannesburg, Cape Town, Durban and Carletonville 
STD clinics during the period 1994 - 1999. All patients were 
of black African ethnicity and the majority (97%) were male. 
Patients were eligible to enter these studies if they presented 
with visible genital ulceration(s) of at least 2 mm in diameter 
with or without inguinal and/or femoral lymphadenopathy. 
However, they were subsequently excluded if they had a 
history of treatment with antibiotics, or had received antiviral 
therapy during the past 7 days, or failed to give oral informed 
consent for completion of a questionnaire and collection of 
clinical specimens.
Laboratory methods
In each case, material from the bases of target lesions was 
collected using a cotton-tipped swab (Medical Wire and 
Equipment, Corsham, UK). Each swab was then expressed 
into 0.2 ml sterile distilled water and stored frozen at –70°C 
until analysed. Subsequently, a multiplex polymerase chain 
reaction (M-PCR) assay (Roche Molecular Systems) was used 
to detect specific target sequences of DNA from T. pallidum, 
Haemophilus ducreyi, and HSV from the swabs. An aliquot of the 
processed specimen was also used in a Chlamydia trachomatis 
PCR test (Amplicor, Roche Molecular Systems). All M-PCR 
assays were performed at the Centers for Disease Control and 
Prevention, in Atlanta, Georgia, USA, using methods described 
previously.15
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The authors investigated the utility of both a non-
treponemal (RPR) test and a treponemal (FTA-ABS) test for 
the diagnosis of primary syphilis during the emergence of 
the HIV epidemic in southern Africa. The serological tests 
were performed on 868 patients with genital ulcerations, 
seen in five centres. While primary syphilis was diagnosed 
by multiplex PCR in 163 cases (18.8%), the overall RPR 
and FTA-ABS seroprevalences were 24.3% and 51.5% 
respectively. The sensitivities of the RPR and FTA-ABS to 
detect primary syphilis were 69.3% and 89.6% respectively, 
while the specificities were 86.1% and 58.5% respectively. 
The performance characteristics of these tests were 
influenced negatively by concomitant HIV infection and the 
presence of other genital ulcer disease pathogens in lesions 
found to be Treponema pallidum PCR positive.
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In addition, vacuum collection tubes without anticoagulant 
were used to collect 10 ml of venous blood from each patient. 
After collection, blood specimens were allowed to clot at room 
temperature, centrifuged at 1200 x g for at least 5 minutes 
and the serum subsequently stored at 4°C or frozen at -70°C. 
Serological testing for syphilis was performed using both a 
quantitative non-treponemal RPR test (Immunotrep, Omega 
Diagnostics, Alloa, Scotland, UK) and a treponemal test (FTA-
ABS, Marburg, Germany). HIV testing was performed using 
a rapid test (Capillus HIV-1/HIV-2, Cambridge Biotech, USA) 
and all positive samples were confirmed by an ELISA test 
(AxSYM HIV1/2, Abbott Diagnostics). All indeterminate or 
low-titre positive specimens were further tested using the 
Western Blot method (HIV 2.2 Blot, Genelab Diagnostics).
All HIV-seropositive patients were provided with post-test 
counselling and referred to local HIV clinics for follow-up and 
appropriate management.
All study protocols were approved by the Committee 
for Research on Human Subjects, of the University of the 
Witwatersrand, Johannesburg.
Results
The results of molecular testing to determine the aetiology of 
the ulcerations seen in the five centres are shown in Table I. 
Of 868 patients included in these studies, H. ducreyi (HD) was 
detected by M-PCR in 436 (50.2%), T. pallidum (TP) in 163 
(18.8%), and herpes simplex virus (HSV) in 268 (30.9%), while 
C. trachomatis (CT) was detected by PCR in 29 cases (3.3%). No 
organism could be demonstrated in 88 cases (10.1%). A single 
aetiological agent was detected in 672 cases (77.4%), while 
multiple aetiologies were detected in 108 (12.4%). Among those 
with a single aetiology, HD was detected in 346 (51%), HSV in 
203 (30.2%), TP in 106 (15.8%) and CT in 17 (2.5%) cases. The 
most common mixed infections involved syphilis, chancroid 
and genital herpes. Of 163 TP-positive patients, 57 (34.9%) were 
co-infected with at least one other aetiological agent, namely: 
33 (57.9%) with HD, 13 (22.8%) with HSV, and 7 (12.3%) with 
both.  Co-infection with HD and HSV was also common.
Overall, 211 (24.3%) of sera obtained from these patients 
were reactive in both the RPR and FTA-ABS tests, a further 
236 (27.2%) were reactive in the FTA-ABS test alone, and 421 
(48.5%) were negative for both. No false-positive RPR reactions 
were detected. Among RPR-seropositive patients, 137 (64.9%) 
had a titre of 1:8 or higher (see Fig. 1). The overall geometric 
mean RPR titre was 1:11.5.
The rates of positive syphilis and HIV serology among 
patients with different GUD aetiologies are shown in Table II. 
The highest rate of RPR-seropositivity (69.3%) was found 
among patients with a positive M-PCR-TP. Of 163 M-PCR-TP-
positive patients, the RPR positivity rate was higher in patients 
with single TP infections (79.2%) than in those with mixed 
aetiology involving TP and other agents (50.9%) (χ2 = 14.03, 
p<0.0001). 
The RPR seropositivity rate recorded among patients with a 
positive M-PCR-TP was significantly higher than that recorded 
among patients with a negative M-PCR-TP (69.3% v. 13.9% χ2 = 
216.9, p<0.001). The geometric mean RPR titre of sera collected 
from cases that were solely M-PCR-TP positive was similar to 
that recorded among cases where ulcerations were M-PCR-
TP positive but which had another pathogen detected in the 
same lesion (1:17.1 v. 1:16.8). However, the geometric mean 
titre was significantly lower in RPR-seropositive patients with 
non-treponemal ulcerations (1:5.9) (ANOVA, F statistics = 2.9, 
p<0.05).
Among all patients included in these studies, the rate of FTA-
ABS seropositivity was 51.5%. Of the 657 RPR-seronegative 
patients, 236 (35.9%) were positive by the FTA-ABS test. As 
with the RPR test, patients whose ulcerations were only M-
PCR-TP positive had a higher FTA-ABS seropositivity rate than 
those with other aetiologies recorded (96.2% v. 41.5%, χ2=21.4, 
p<0.001).
The overall HIV seroprevalence among GUD cases was 
46.7%. Of 163 patients who were M-PCR-TP positive, 47 (28.8%) 
were co-infected with HIV. Among patients with a single 
aetiology, the lowest HIV prevalence was found among M-PCR-
Table I. Aetiology of GUD among patients in South Africa 
and Lesotho (1994 - 1999)
Aetiology
No. of 
patients %
Single aetiology (N=672)
Primary syphilis 106 12.2
Chancroid 346 39.9
Genital herpes 203 23.4
LGV 17 2.0
Multiple aetiology (N=108)
Primary syphilis & chancroid 33 3.8
Primary syphilis & g. herpes 13 1.5
Primary syphilis, chancroid & g. herpes 7 0.8
Primary syphilis & LGV 3 0.3
Primary syphilis, chancroid & LGV 1 0.1
Chancroid & g. herpes 43 5.0
Chancroid & LGV 6 0.7
G. herpes & LGV 2 0.2
Indeterminate 88 10.1
Total 868 100.0
LGV = lymphogranuloma venereum.
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Fig. 1. Distribution of RPR titres in 211 GUD patients with a positive 
RPR test.
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TP positive cases (20.8%). However, a higher HIV prevalence 
rate (43.9%) was recorded in cases that were M-PCR-TP positive 
but mixed with other aetiological agents (43.9% v. 20.8%, 
χ2=9.64, p<0.001). The highest HIV prevalence of 329/617 
(53.3%) was found in patients infected with non-treponemal 
causes of ulceration.
When comparing RPR seropositivity rates by HIV serostatus, 
the RPR test was positive in 27 HIV-positive/M-PCR-TP-
positive cases (57.4%) compared with 86 patients (74.1%) in 
the HIV-negative/M-PCR-TP group (OR 0.47, 95% CI 0.23 - 
0.96, p<0.05). Irrespective of their RPR status, no significant 
difference in FTA-ABS seropositivity rates was found among 
HIV-seropositive and -seronegative M-PCR-TP positive patients 
(83% v. 92.2%, NS). Eight HIV-positive patients (17%) and 9 
HIV-negative patients (7.8%) who were M-PCR-TP positive 
were negative by both serological tests for syphilis. There was 
no significant difference in the geometric mean titres of the 
RPR test when comparing HIV-seropositive and -seronegative 
patients with a positive RPR test (1:13.7 v. 1:18.2, respectively).
Among 163 M-PCR (TP)-positive patients, 106 (65%) were 
solely infected by TP and 57 (34.9%) had mixed infections with 
other aetiological agents. Of the 106 patients with a single 
aetiology, 22 (20.8%) were co-infected with HIV. There was 
no significant difference in RPR positivity rates between HIV-
seropositive and -seronegative groups with a single TP infection 
(81.8% v. 78.6%, Fisher’s exact test NS). However, a significant 
difference in the RPR seropositivity rates between HIV-positive 
and -negative groups with mixed GUD aetiologies was detected 
(36.0% v. 62.5%, χ2 = 3.9, p<0.05).
Of 705 patients with a negative M-PCR-TP test, 358 (50.8%) 
were co-infected with HIV, and the overall RPR seropositivity 
rate was 13.9%. The RPR seropositivity rate in HIV-seropositive 
patients was 12.3% and in HIV-seronegative patients 15.6% 
(χ2=1.6, p=0.2). The RPR seropositivity rate detected in patients 
with indeterminate laboratory findings was significantly higher 
than that seen in patients with known aetiologies other than 
TP (28.4% v. 11.8%, χ2=17.7, p<0.001), indicating that some 
cases of primary syphilis were not detected by the M-PCR-TP. 
This significance was independent of HIV serostatus (HIV-
seropositives: 24.1% v. 11.2%, χ2=4.1, p=0.04; HIV-seronegative 
group: 30.5% v. 12.5%, χ2=12.1, p<0.001).
A comparison of the performance of syphilis serology in 
HIV-seropositive and -seronegative patients with single and 
mixed infections is shown in Table III. Eighty-eight patients 
with unknown or indeterminate aetiology were excluded from 
this analysis. The overall sensitivity of RPR to detect primary 
syphilis in our setting was 69.3% and its specificity was 86.1%, 
while the sensitivity and specificity of the FTA-ABS test were 
89.6% and 58.5% respectively. Unfortunately, this test, in 
common with other treponemal tests, exhibited poor specificity 
for the detection of primary disease because it measures lifetime 
exposure to T. pallidum infection and was found to be reactive 
in many cases of ulceration that were M-PCR-TP negative. The 
sensitivity of the RPR test was found to be significantly higher 
in HIV-seronegative than HIV-seropositive patients (74% v. 
57.4%, χ2= 4.94, p=0.026). The sensitivity of the RPR test was 
further decreased (to 36%) in HIV-seropositive patients with 
mixed infections. Among HIV-seropositive patients, there was 
a significant difference in the sensitivity of the RPR test in 
patients infected solely by TP when compared to those who 
had mixed TP infections (81.8% v. 36%, p<0.001). However, this 
difference was not statistically significant when comparing 
patients who were HIV-seronegative.
Discussion
As has been demonstrated previously in southern Africa,  the 
utility of both treponemal and non-treponemal serological 
tests for the diagnosis of primary syphilis is questionable,16 
Table II. Syphilis and HIV seroprevalence by aetiology of genital ulcer disease
     Both RPR & FTA-ABS +ve Both RPR &  
   Number of  FTA-ABS +ve only  FTA-ABS –ve HIV-positive 
Aetiology   patients                No. % No. % No. % No.   %
Single aetiology
Primary syphilis        106                84 79.2 18 17.0 4 3.8 22 20.8
Chancroid       346                45 13.0 115 33.2 186 53.8 163 47.1
Genital herpes       203                14 6.9 49 24.1 140 69.0 126 62.1
LGV        17                3  17.6 5 29.4 9 52.9 10 58.8
Multiple aetiology
Primary syphilis & chancroid      33                17 51.5 6 18.2 10 30.3 14 42.4
Primary syphilis & g. herpes      13                6  46.2 6 46.2 1 7.7 7 53.8
Primary syphilis, chancroid      7                4  57.1 2 28.6 1 14.3 3 42.9
& g. herpes
Primary syphilis & LGV      3                2  66.7 -  1 33.3 1 33.3
Primary syphilis, chancroid      1                -  1 100.0   - - 
& LGV
Chancroid & g. herpes      43                9  20.9 10 23.3 24 55.8 27 62.8
Chancroid & LGV       6                2  33.3 3 50.0 1 16.7 2 33.3
G. herpes & LGV       2                -  1 50.0 1 50.0 1 50.0
Indeterminate       88                25 28.4 20 22.7 43 48.9 29 33.0
Total        868                211 24.3 236 27.2 421 48.5 405 46.7
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since many patients with primary syphilis are seronegative 
(especially by the RPR test), while others with ulcerations 
caused by other organisms are seropositive (especially by the 
FTA-ABS test) as a result of previously treated treponemal 
infections. In these studies, we have examined the effect of 
HIV co-infection in patients with M-PCR-confirmed primary 
syphilis on the performance of treponemal and non-treponemal 
serological tests. Previous studies have reported atypical 
treponemal and nontreponemal serological responses in HIV-
infected individuals with syphilis, such as false negative tests 
or a delay in seroconversion12,14  and falsely positive serological 
responses.10,11 In the study reported here, no biological false 
positive RPR reactions were detected among HIV-seropositive 
patients. This may be a phenomenon which is more associated 
with intravenous drug abuse than the direct effect of HIV 
infection; unlike populations studied in more industrialised 
countries, intravenous drug abuse is rare among patients co-
infected with syphilis and HIV in southern Africa.
Only 69.3% of patients with M-PCR-confirmed TP infection 
were found to be RPR-seropositive, and the rate of RPR 
seropositivity among primary syphilis patients co-infected with 
HIV (57.4%) was significantly lower than that recorded among 
patients without HIV co-infection (74.1%). These results are 
consistent with a delay in antibody formation occurring as a 
result of HIV infection and subsequent immunosuppression. 
However, the rate of RPR seropositivity was also significantly 
reduced among those patients presenting with TP mixed 
with other GUD aetiological agents (50.9%) when compared 
with those with a single TP infection (79.2%). This effect was 
also seen among HIV-negative patients – with a significantly 
reduced rate of RPR seropositivity in those with mixed 
infections. The utility of RPR tests in detecting primary syphilis 
may be reduced further in areas where both HIV-coinfection as 
well as GUD with multiple aetiologies are common. 
In southern Africa, the HIV epidemic reached maturity in the 
late 1990s, with an increasing number of immunocompromised 
patients having been recorded. Most patients with genital 
herpes who were included in the studies reported here 
presented with non-vesicular, purulent ulcerations that 
would usually be diagnosed clinically as chancroid. These 
chronic ulcers could subsequently serve as a portal of entry 
for T. pallidum, resulting in mixed infections and a delay 
in development of antibody responses to this ‘secondary’ 
infection. Regardless of the underlying mechanism of this 
decrease in sensitivity, it is clear that caution should be 
exercised in the interpretation of syphilis serological testing in 
cases of GUD, particularly in those who are co-infected with 
HIV, because many cases of primary syphilis may be associated 
with other causes of GUD.
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Table III. Performance of syphilis serology in the diagnosis of primary syphilis
RPR
p
FTA-ABS
  pSingle infection Mixed infection Single infection Mixed infection
HIV-seropositive
Sensitivity 18/22 (81.8%) 9/25 (36%) 0.001 21/22 (95.5%) 18/25 (72%) 0.08
Specificity 271/299 (90.6%) 21/30 (70%) 0.002 175/299 (58.5%) 14/30 (54.5%) 0.58
PPV 18/46 (39.1%) 9/18 (50%) 0.4 21/145 (14.5%) 18/34 (52.9%) 0.001
NPV 271/275 (98.5%) 21/37 (56.8%) 0.001 175/176 (99.4%) 14/21 (66.7%) 0.27
HIV-seronegative
Sensitivity 66/84 (78.6%) 20/32 (62.5%) 0.08 81/84 (96.4%) 26/32 (81.3%) 0.02
Specificity 233/267 (87.3%) 19/21 (90.5%) 0.9 160/267 (59.9%) 12/21 (57.1%) 0.8
PPV 66/100 (66%) 20/22 (90.9%) 0.02 81/188 (43.1%) 26/35 (74.3%) 0.001
NPV 233/251 (92.8%) 19/31 (61.3%) 0.001 160/163 (98.2%) 6/18 (66.7%) 0.02
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